Coptis (Goldthread) for Anti-Inflammatory

Research suggests that berberine, a primary active compound found in Coptis and several other botanical sources, demonstrates anti-inflammatory and antioxidant properties based on laboratory and animal studies, with some human clinical trial evidence pointing to reductions in blood vessel inflammation and improvements in cardiometabolic markers. The available evidence comes largely from a 2016 review examining berberine across multiple chronic disease contexts, which found a generally supportive direction for its anti-inflammatory effects, though much of the mechanistic work remains at the preclinical stage. Studies indicate the compound shows promise, but the evidence base is limited in scope, and the findings from reviews and laboratory models do not necessarily translate directly to established therapeutic outcomes in humans. Readers should note that berberine is shared across multiple plant sources, so findings are not exclusive to Coptis specifically.